Literature DB >> 17890788

Cardiac and noncardiac, particularly neuromuscular, disease with troponin-T positivity.

J Finsterer1, C Stöllberger, W Krugluger.   

Abstract

OBJECTIVES: Although elevated cardiac troponin T is caused by myocardial damage in the vast majority of the cases (primary cardiac causes), noncardiac disease with secondary damage to the myocardium (secondary cardiac causes) is being increasingly recognised. The present study aimed to retrospectively evaluate the frequency of primary cardiac and secondary cardiac causes of troponin-T positivity, in particular how often troponin-T positivity is associated with neuromuscular disorders.
RESULTS: Of 16,944 troponin-T determinations in a secondary centre between April 2004 and April 2005, troponin T was positive in 1408 of them (8.3%). Of these, 622 were included for evaluation. Troponin-T positivity was associated with elevated creatine kinase in 54.5% and with creatinine >2 mg/dl (177 micromol/l) in 16.6% of the tests. The most frequent primary cardiac causes of troponin-T positivity were myocardial ischaemia (59%), atrial fibrillation (23%), and heart failure (22%). The most frequent secondary cardiac causes of troponin-T positivity were renal insufficiency (22%), chronic obstructive lung disease (10%), and acute stroke (4%). There was one cause for troponin-T positivity in 249 cases and more than one in 373 cases. A neurologist saw patients with troponin-T positivity in 9.5% of the cases. Troponin-T positivity was associated with a neuromuscular disorder in 6.3% of the cases. Causes of troponin-I positivity were also frequently causes of troponin-T positivity.
CONCLUSIONS: Ischaemic heart disease is the most frequent cause of troponin-T positivity, followed by heart failure and renal insufficiency. Many causes previously described to be only responsible for troponin-I positivity also cause troponin-T elevation. Troponin-T positivity is frequently associated with neuromuscular disorders, most likely due to cardiac involvement of these conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890788

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  9 in total

Review 1.  Non-coding RNAs as biomarkers for acute myocardial infarction.

Authors:  Chen Wang; Qing Jing
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

2.  Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis.

Authors:  Feng Wang; Guangwen Long; Chunxia Zhao; Huaping Li; Sandip Chaugai; Yan Wang; Chen Chen; Dao Wen Wang
Journal:  J Transl Med       Date:  2013-09-23       Impact factor: 5.531

3.  Atherosclerosis-related circulating miRNAs as novel and sensitive predictors for acute myocardial infarction.

Authors:  Feng Wang; Guangwen Long; Chunxia Zhao; Huaping Li; Sandip Chaugai; Yan Wang; Chen Chen; Dao Wen Wang
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

4.  sMICA as novel and early predictors for acute myocardial infarction.

Authors:  Cunyu Fu; Yunxiang Shi; Zongqin Yao
Journal:  Eur J Med Res       Date:  2016-06-16       Impact factor: 2.175

5.  Circulating miR-26a-1, miR-146a and miR-199a-1 are potential candidate biomarkers for acute myocardial infarction.

Authors:  Sheng Xue; Wenjie Zhu; Dacheng Liu; Zhe Su; Liwei Zhang; Qing Chang; Peifeng Li
Journal:  Mol Med       Date:  2019-05-15       Impact factor: 6.354

6.  Silence of miR-32-5p promotes endothelial cell viability by targeting KLF2 and serves as a diagnostic biomarker of acute myocardial infarction.

Authors:  Yunxiang Dai; Tingguo Yan; Yuming Gao
Journal:  Diagn Pathol       Date:  2020-03-03       Impact factor: 2.644

7.  Regulatory Mechanism of LINC00152 on Aggravating Heart Failure through Triggering Fibrosis in an Infarcted Myocardium.

Authors:  Lizhong Song; Xiujuan Duan; Xiaojuan Zeng; Xinglian Duan; Li Li
Journal:  Dis Markers       Date:  2021-12-01       Impact factor: 3.434

Review 8.  Identification of microRNAs as diagnostic biomarkers for acute myocardial infarction in Asian populations: A systematic review and meta-analysis.

Authors:  Qian Wang; Junfen Ma; Zhiyun Jiang; Fan Wu; Jiedan Ping; Liang Ming
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

Review 9.  Noncoding RNAs as Biomarkers for Acute Coronary Syndrome.

Authors:  Lijie Wang; Yuanzhe Jin
Journal:  Biomed Res Int       Date:  2020-04-01       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.